Modulation of blood-tumor barrier transcriptional programs improves intra-tumoral drug delivery and potentiates chemotherapy in GBM.
Jimenez-Macias JL, Vaughn-Beaucaire P, Bharati A, Xu Z, Forrest M, Hong J, Sun M, Schmidt A, Clark J, Hawkins W, Mercado N, Real J, Huntington K, Zdioruk M, Nowicki MO, Cho CF, Wu B, Li W, Logan T, Manz KE, Pennell KD, Fedeles BI, Brodsky AS, Lawler SE.
Jimenez-Macias JL, et al. Among authors: forrest m.
bioRxiv [Preprint]. 2024 Aug 28:2024.08.26.609797. doi: 10.1101/2024.08.26.609797.
bioRxiv. 2024.
PMID: 39253453
Free PMC article.
Preprint.